系统性自身免疫性风湿病(SARDs)中自我报告的认知功能障碍与记忆损害:INSPIRE队列的混合方法分析
该混合方法研究调查了1853例系统性自身免疫性风湿病患者和463例对照,使用日常记忆问卷修订版(EMQ-R)等工具评估自我报告的认知功能障碍。结果显示SLE、未分化结缔组织病和干燥综合征患者的记忆损害报告率显著高于其他组,且EMQ评分与疾病活动度正相关、与幸福感负相关。定性访谈揭示认知功能障碍对日常生活、社交和自尊的负面影响及症状的低报现象。
要点
- SLE、UCTD和干燥综合征患者自我报告的记忆损害率显著高于其他SARD组。
- EMQ-R评分与整体疾病活动度自评正相关(r=0.291,P<0.001),与幸福感负相关(r=-0.397,R2=0.159)。
- 定性分析提示认知症状对日常活动、社交隔离、自尊和心理健康有不良影响,且可能被低报给临床医生。
核心结论
- 研究强调SARDs中存在显著记忆损害,尤其是SLE、UCTD和干燥综合征,且认知损害影响日常生活和幸福感。
- 与疾病活动度和神经精神症状的正相关及与幸福感的负相关强调需要针对性干预,未来研究应优先开发药物和心理社会干预。
- 虽然无证据表明记忆损害随时间恶化,但症状低报提示认知问题可能比临床记录更普遍,强调全面患者评估的重要性。
研究设计与样本
- 采用混合方法,调查1853例SARD患者和463例对照,使用包括EMQ-R在内的验证工具。
- 使用Kruskal-Wallis检验和Spearman秩相关比较组间差异,并进行67次深度访谈的定性主题分析。
主要发现
- SLE、UCTD和干燥综合征患者报告的记忆损害率显著高于其他组。
- 无证据显示自我报告的记忆损害随疾病病程或年龄增加。
- EMQ评分与所有其他神经精神症状的终生频率呈中度正相关。
- EMQ-R与整体疾病活动度自评正相关(r=0.291,P<0.001),与幸福感负相关(r=-0.397,R2=0.159)。
- 定性分析强调认知功能障碍对日常活动参与、社交隔离、自尊和心理健康的不良影响,以及症状可能被低报给临床医生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore self-reported cognitive dysfunction, including memory impairment, across systemic autoimmune rheumatic diseases (SARDs) and examine its impact and associations with demographic, clinical and psychosocial factors. METHODS: A mixed-methods approach was employed, surveying 1853 SARD patients and 463 controls using validated instruments including the Everyday Memory Questionnaire-Revised (EMQ-R). Kruskal-Wallis tests and Spearman's rank correlations were used to compare the groups. Additionally, 67 in-depth interviews were conducted for qualitative thematic analysis. RESULTS: Systemic lupus erythematosus (SLE), undifferentiated connective tissue disease (UCTD) and Sjögren's patients reported significantly higher rates of memory impairments than other groups. There was no evidence of increased self-reported memory impairment with disease duration or age. Moderate positive associations were found between EMQ scores and the lifetime frequency of all other neuropsychiatric symptoms. EMQ-R was positively associated with self-assessment of overall disease activity (r = 0.291, P < 0.001) and negatively correlated with well-being (r = -0.397, R2 = 0.159). Expanding on the quantitative findings, qualitative analyses highlighted the adverse impact of cognitive dysfunction on daily participation in activities, social isolation, self-esteem and mental well-being, and the potential underreporting of these symptoms to clinicians. CONCLUSION: This study highlights a significant impairment of memory in SARDs, notably in SLE, UCTD and Sjögren's, and the impact of cognitive impairment on daily lives and well-being. The positive associations with disease activity and neuropsychiatric symptoms, and negative association with well-being emphasizes the need for targeted interventions. Future research should prioritize developing pharmacological and psychosocial interventions to address cognitive dysfunction in SARD patients. While reassuringly there was no evidence of worsening memory impairment over time, the underreporting of symptoms also suggests that cognitive issues may be more prevalent than clinical records indicate and thus emphasize the importance of thorough patient assessment.
引用
- Varshney A, Pollak TA, Arunasalam A, et al. Self-reported cognitive dysfunction and memory impairment in Systemic Autoimmune Rheumatic Diseases (SARDs): a mixed methods analysis of the INSPIRE cohort. Rheumatology (Oxford). 2025. PMID: 40795207. doi:10.1093/rheumatology/keaf429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。